The Nanofacturing consortium has worked on a pan-European nanopharmaceutical project to develop new manufacturing methods and improve supply chain co-ordination to advance treatments for rare cancers, autoimmune diseases and viral infections. The Nanofacturing collaboration has accelerated the development of nanotechnologies with the goal of bringing more targeted and effective therapies to market.
For more information see the IDTechEx report on Biobased Polymers 2018-2023. Specifically, the eight-partner project has centred upon the processing of glycan-coated gold nanoparticles, which have the ability to circulate freely in the blood and, with the addition of targeting ligands, to preferentially enter diseased cells or antigen-processing cells of the immune system.
These small nanoparticles, to which therapeutic drugs or immunotherapeutic peptides can be attached, can pass across blood vessels to deliver medicine directly to diseased sites before being excreted from the body.
Areitio Junquera, Project Co-Ordinator from Midatech Pharma, said:
“This rapidly emerging technology has the potential to deliver drugs more effectively and in a kinder way to patients. Preclinical studies have demonstrated how highly toxic, anti-cancer drugs can be specifically targeted to tumour cells while sparing normal tissue, and how antigenic peptides can be delivered with improved potency to the immune system. Over the course of the project, clinical grade gold nanoparticle treatments have been manufactured and are now being investigated in clinical trials.”
Nanocarriers, which include glycan-coated gold nanoparticles, are forecast to account for 40 per cent of a $136 billion nanotechnology-enabled drug delivery market by 2021(1). However, their development has previously suffered from a number of challenges, with scale-up of production from pre-clinical, laboratory scale to clinical testing hampered by a lack of pilot manufacturing capacity and supply chain infrastructure. High development costs have also prevented SMEs from taking gold nanoparticle drug programs to commercialisation.
News This Week
DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries [...]
These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others. As the digital health sector matures from basic tracking apps into highly regulated medical devices, we are seeing bleeding edge [...]
Quantum technologies utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing. However [...]
Nanoparticles can be used in many ways as catalysts. To be able to tailor them in such a way that they can catalyse certain reactions selectively and efficiently, researchers need to determine the properties [...]
University of Copenhagen researchers have developed a nanocomponent that emits light particles carrying quantum information. Less than one-tenth the width of a human hair, the miniscule component makes it possible to scale up [...]
Once cartilage is damaged, there is little that can be done to repair it. Unlike many other tissues, cartilage doesn’t heal well and consequences of injuries and disease can last a lifetime. Now [...]
Bacteria across our planet contain nanometer-sized factories that do many different things. Some make nutrients, others isolate toxic materials that could harm the bacteria. We have barely scratched the surface of their functional diversity. [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - May 2 2019 Since [...]
Researchers from University of Jyväskylä and Aalto University in Finland have developed a customized DNA nanostructure that can perform a predefined task in human body-like conditions (ACS Nano, "Reconfigurable DNA Origami Nanocapsule for pH-Controlled [...]
Some of the most famous scientific discoveries happened by accident. From Teflon and the microwave oven to penicillin, scientists trying to solve a problem sometimes find unexpected things. This is exactly how we created [...]
When diagnosed with a disease, it's often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they're offered and identify the best experts to help. Complexity [...]
The NanoMedicines Innovation Network (NMIN) has been awarded $18.5 million in new funding from the Networks of Centres of Excellence (NCE), a federal program that connects teams of scientists across Canada to collaborate on [...]
Young researchers from Siberian Federal University (SibFU) along with their colleagues from FRC KSC SB RAS are designing a technology for producing multilayer gilded nanodisks for targeted drug delivery and treating cancer using dip [...]
Frank Boehm: Publication of our new paper “Human Brain/Cloud Interface” in Frontiers in Neuroscience
Contributors: Nuno R. B. Martins, Amara Angelica, Yuriy Svidinenko, Frank J. Boehm, Ioan Opris, Mikhail A. Lebedev, Melanie Swan, Steven A. Garan, Jeffrey V. Rosenfeld, Tad Hogg, Robert A. Freitas Jr. et al Excerpt [...]
Abstract The progressive growth in nanotechnology approaches to diagnostics and therapeutics, especially for cancer, necessitates training physicians in nanoethics. This article explains why it is critical for medical education to include instruction in [...]